APA (7th ed.) Citation

Foroni, L., Mitchell, W., Rai, L., Richards, S., Fielding, A., & Goldstone, A. (2005). The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.

Chicago Style (17th ed.) Citation

Foroni, L., W. Mitchell, L. Rai, S. Richards, A. Fielding, and A. Goldstone. The Value of Molecular Monitoring for Residual Disease (MRD) in Early Morphological Remitters Among Adults Diagnosed with B Cell ALL and Treated According to the MRC UKALL12 Protocol. 2005.

MLA (9th ed.) Citation

Foroni, L., et al. The Value of Molecular Monitoring for Residual Disease (MRD) in Early Morphological Remitters Among Adults Diagnosed with B Cell ALL and Treated According to the MRC UKALL12 Protocol. 2005.